Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3212 AdvaMed’s Legal Committee works with in-house lawyers and compliance officers at member companies around the world to help foster a predictable legal environment that values innova- tive health care solutions, enhances public health and ensures patient access to the latest advancements in medical technol- ogy. The legal team also engages diverse stakeholder groups, including government regulators, physician specialty societies and others, to advance the highest global standards for ethical interactions between industry and health care professionals. U.S. PHYSICIAN PAYMENTS SUNSHINE ACT In 2015, AdvaMed engaged extensively with the Centers for Medicare and Medicaid Services (CMS) on implementation of the Sunshine Act, seeking to ensure an efficient disclosure process and that published data offers meaningful information to patients about industry-physician collaborations. The Asso- ciation worked to resolve members’ implementation concerns, including a proposal to combine physician Medicare payment data and Sunshine Act data on the CMS website, which CMS deferred in response to AdvaMed advocacy, and the question of whether medical journal reprints and payments supporting continuing medical education should be reportable, which continues to be discussed. ETHICS & COMPLIANCE AdvaMed leads the promotion of ethical business environments in the medtech sector, consistent with the AdvaMed Code of Ethics on Interactions with Health Care Professionals (the AdvaMed Code). Among the Association’s 2015 accomplishments: •  AdvaMed organized and led industry-wide distrib- utor training sessions in Latin America and Southern Europe focused on unique anti-corruption risks faced by third-party distributors in emerging markets, as well as ethical interactions, best-practices and compli- ance tools. •  AdvaMed – jointly with Med- Tech Europe – released new anti-bribery/anti-corruption compliance guidance with hypothetical scenarios and examples of steps companies can take to minimize third-party risk. •  AdvaMed held its eighth annual Global MedTech Compliance Conference in May in Athens, Greece, which brought together more than 250 compliance professionals to discuss global trends facing the medtech industry. In February, we held our fourth annual Latin America Compliance Conference in Mexico City, Mexico. •  In the Asia-Pacific region, AdvaMed continued to play a leading role in the Asia- Pacific Economic Coopera- tion (APEC) business ethics initiative, working to advance 11 new high- standard codes of ethics that have been adopted by medical technology industry associations. •  AdvaMed launched its Code of Ethics on Interactions with Health Care Professionals INNOVATIONADVOCATE L E G A L A F F A I R S AdvaMed Senior Executive Vice President and General Counsel Chris White (at right) leads AdvaMed’s Latin America Compliance Conference in Mexico City with Pablo F. Davila, president of AMID, the Mexican Association of Innovative Medical Device Industries, who is also C.R. Bard’s head of Latin America North. INNOVATION AGENDA PILLAR 3 Reform the U.S. tax system to create a level playing field, starting with repeal of the medical device tax, a tax that is draining resources from American manu­ facturing jobs and research. A D V A M E D 2 0 1 5 A N N U A L R E P O R T